"These extended and sustained benefits appear to be primarily driven by a reduction in the rate of non-fatal MI, suggesting that the principal benefit of CCTA [coronary CT angiography] is driven by ...

The benefits of noninvasive imaging may soon be available to patients at high risk of coronary artery disease, according to researchers studying a newer technology. That technology is called ...

A new study found that a non-invasive, AI enabled Coronary Computer Tomography Angiography effectively identified stenosis equally well or better than the conventional gold standard of invasive ...

For people with stable chest pain and an intermediate pretest probability of obstructive coronary artery disease (CAD), an initial CT strategy fared similarly to invasive coronary angiography (ICA) ...

Coronary CT angiography for the suspected progression of known coronary artery disease in a 60-year-old female patient. Curved multiplanar reconstructions with 0.6- (yellow outline), 0.4- (blue ...

CT coronary angiography (CTCA) was found to be safe and effective for evaluating coronary artery disease in patients with a low-to-intermediate pretest probability of the disease. It demonstrated a ...

After controlling for known CV risk factors, all FFR-CT subgroups remained significantly associated with MI, revascularization. (HealthDay News) — For patients with coronary artery disease (CAD), ...

Please provide your email address to receive an email when new articles are posted on . Quality of life and angina burden were similar after CT or invasive angiography for CAD diagnosis. Women ...

MADRID, Spain—Routine use of CT angiography after PCI for left main coronary artery disease does not lower the risk of major adverse cardiac events, results of the PULSE trial show. There was a signal ...

Please provide your email address to receive an email when new articles are posted on . In patients with stable chest pain and intermediate pretest probability of CAD, risk for major adverse CV events ...

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name. The newly published results of a study show that the New York City-based ...